HEDIS® Tip Sheet

Statin Therapy for Patients with Cardiovascular Disease (SPC)

Line of business: BlueAlliance (Commercial) & BlueAlliance Care+ (Medicaid)

Measure Description

The percentage of males 21-75 years of age and females 40-75 years of age who were identified as having clinical atherosclerotic cardiovascular disease (ASCVD) and met the following criteria:

  • Received Statin Therapy: Members who were given at least one high-intensity or moderate-intensity statin medication.
  • Stating Adherence 80%: Members who remained on a high-intensity or moderate-intensity statin medication for at least 80% of the treatment period.
Icon of a check mark and a document

Clinical ASCVD includes:

  • Myocardial Infarction (MI)
  • Coronary Artery Bypass Graft (CABG)
  • Percutaneous Coronary Intervention (PCI)
  • Other revascularization procedures.

Received Statin Therapy Compliance:

  • Eligible population as determined by event/diagnosis, who have had at least one dispensing event for high or moderate intensity statin medication during the measurement year.

Statin Adherence 80% Compliance:

  • Members who received a proportion of days covered of at least 80% during the treatment period.
Icon of a check mark and a document with a person

Best Practices

  • Educate patients on the importance of adherence to prescribed medication regimen.
  • Include patient concerns/input in decision making processes for a treatment plan they can adhere to (i.e., once daily dosing, generic options, and medications to minimize side effects).
  • Schedule and encourage routine follow-up and monitoring.
Icon of a document with a red letter X in the bottom right

Exclusions

Members with any of the following during the measurement year or the year prior to the measurement year:

  • Pregnancy diagnosis
  • In vitro fertilization
  • End stage renal disease or dialysis
  • Cirrhosis
  • Dispensed at least one prescription for clomiphene (estrogen agonist).

Members with the following during the measurement year:

  • Myalgia, myositis, myopathy, rhabdomyolysis

Other Exclusions include:

  • Members in hospice during the measurement year.
  • Members who received palliative care during the measurement year.
  • Members who died during the measurement year.
  • Members 66+ years of age with frailty and advanced illness. Members must meet BOTH the frailty and advanced illness criteria to be excluded:
    • 1. At least two indicators of frailty with different dates of service during the measurement period.
    • 2. Any of the following during the measurement year or the year prior to the measurement year:
      • At least two outpatient visits, observation visits, ED visits, telephone visits, e-visits, or virtual check-ins, nonacute inpatient encounters, or nonacute inpatient discharges on different dates of service with an advanced illness diagnosis.
      • At least on acute inpatient encounter with an advanced illness diagnosis.
      • At least one acute inpatient discharge with an advanced illness diagnosis on the discharge claim.
  • A dispensed dementia medication.

High- and Moderate-Intensity Statin Medications



Coding Disclaimer

The analysis of any medical coding question related to a measure is dependent on the measure’s technical specifications including the factual situations present related to the member, the practice, the professionals, and the medical services provided.

Questions  

Should you have specific coding or other questions related to the measure, please send your questions to BlueAlliance@bcbsnd.com.

 

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).